These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 24694339

  • 1. Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis.
    Tritos NA, Johannsson G, Korbonits M, Miller KK, Feldt-Rasmussen U, Yuen KC, King D, Mattsson AF, Jonsson PJ, Koltowska-Haggstrom M, Klibanski A, Biller BM.
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2018-29. PubMed ID: 24694339
    [Abstract] [Full Text] [Related]

  • 2. Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database.
    Kelestimur F, Jonsson P, Molvalilar S, Gomez JM, Auernhammer CJ, Colak R, Koltowska-Häggström M, Goth MI.
    Eur J Endocrinol; 2005 Apr; 152(4):581-7. PubMed ID: 15817914
    [Abstract] [Full Text] [Related]

  • 3. Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database).
    Verhelst J, Kendall-Taylor P, Erfurth EM, Price DA, Geffner M, Koltowska-Häggström M, Jönsson PJ, Wilton P, Abs R.
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4636-43. PubMed ID: 15928246
    [Abstract] [Full Text] [Related]

  • 4. GH deficiency after traumatic brain injury: improvement in quality of life with GH therapy: analysis of the KIMS database.
    Gardner CJ, Mattsson AF, Daousi C, Korbonits M, Koltowska-Haggstrom M, Cuthbertson DJ.
    Eur J Endocrinol; 2015 Apr; 172(4):371-81. PubMed ID: 25583905
    [Abstract] [Full Text] [Related]

  • 5. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U, Wilton P, Jonsson P, KIMS Study Group, KIMS International Board.
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
    [Abstract] [Full Text] [Related]

  • 6. Growth hormone deficient patients after traumatic brain injury--baseline characteristics and benefits after growth hormone replacement--an analysis of the German KIMS database.
    Kreitschmann-Andermahr I, Poll EM, Reineke A, Gilsbach JM, Brabant G, Buchfelder M, Fassbender W, Faust M, Kann PH, Wallaschofski H.
    Growth Horm IGF Res; 2008 Dec; 18(6):472-8. PubMed ID: 18829359
    [Abstract] [Full Text] [Related]

  • 7. New Neoplasm During GH Replacement in Adults With Pituitary Deficiency Following Malignancy: A KIMS Analysis.
    Krzyzanowska-Mittermayer K, Mattsson AF, Maiter D, Feldt-Rasmussen U, Camacho-Hübner C, Luger A, Abs R.
    J Clin Endocrinol Metab; 2018 Feb 01; 103(2):523-531. PubMed ID: 29228199
    [Abstract] [Full Text] [Related]

  • 8. Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.
    van Varsseveld NC, van Bunderen CC, Franken AA, Koppeschaar HP, van der Lely AJ, Drent ML.
    Pituitary; 2016 Aug 01; 19(4):381-90. PubMed ID: 27048484
    [Abstract] [Full Text] [Related]

  • 9. Effect of long-term GH replacement therapy on cardiovascular outcomes in GH-deficient patients previously treated for acromegaly: a sub-analysis from the Dutch National Registry of Growth Hormone Treatment in Adults.
    van Bunderen CC, van Varsseveld NC, Heymans MW, Franken AA, Koppeschaar HP, van der Lely AJ, Drent ML.
    Eur J Endocrinol; 2014 Dec 01; 171(6):717-26. PubMed ID: 25227133
    [Abstract] [Full Text] [Related]

  • 10. Effect of growth hormone treatment on diastolic function in patients who have developed growth hormone deficiency after definitive treatment of acromegaly.
    Fazeli PK, Teoh JG, Lam EL, Gerweck AV, Wexler TL, Teo EP, Russell BM, Durst R, McCarty D, Weiner RB, Picard MH, Klibanski A, Miller KK.
    Growth Horm IGF Res; 2016 Feb 01; 26():17-23. PubMed ID: 26774401
    [Abstract] [Full Text] [Related]

  • 11. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R, Mattsson AF, Bengtsson BA, Feldt-Rasmussen U, Góth MI, Koltowska-Häggström M, Monson JP, Verhelst J, Wilton P, KIMS Study Group.
    Growth Horm IGF Res; 2005 Oct 01; 15(5):349-59. PubMed ID: 16168692
    [Abstract] [Full Text] [Related]

  • 12. The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: results of the German KIMS database.
    Spielhagen C, Schwahn C, Möller K, Friedrich N, Kohlmann T, Moock J, Kołtowska-Häggström M, Nauck M, Buchfelder M, Wallaschofski H.
    Growth Horm IGF Res; 2011 Feb 01; 21(1):1-10. PubMed ID: 21093334
    [Abstract] [Full Text] [Related]

  • 13. Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database).
    Popovic V, Mattsson AF, Gaillard RC, Wilton P, Koltowska-Häggström M, Ranke MB.
    J Clin Endocrinol Metab; 2010 Sep 01; 95(9):4449-54. PubMed ID: 20610598
    [Abstract] [Full Text] [Related]

  • 14. Tumor Recurrence or Regrowth in Adults With Nonfunctioning Pituitary Adenomas Using GH Replacement Therapy.
    van Varsseveld NC, van Bunderen CC, Franken AA, Koppeschaar HP, van der Lely AJ, Drent ML.
    J Clin Endocrinol Metab; 2015 Aug 01; 100(8):3132-9. PubMed ID: 26057181
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease.
    Feldt-Rasmussen U, Abs R, Bengtsson BA, Bennmarker H, Bramnert M, Hernberg-Ståhl E, Monson JP, Westberg B, Wilton P, Wüster C, KIMS International Study Board of KIMS Study Group.
    Eur J Endocrinol; 2002 Jan 01; 146(1):67-74. PubMed ID: 11751070
    [Abstract] [Full Text] [Related]

  • 16. Traumatic brain injury as a relevant cause of growth hormone deficiency in adults: A KIMS-based study.
    Casanueva FF, Leal A, Koltowska-Häggström M, Jonsson P, Góth MI.
    Arch Phys Med Rehabil; 2005 Mar 01; 86(3):463-8. PubMed ID: 15759229
    [Abstract] [Full Text] [Related]

  • 17. Growth hormone deficiency in treated acromegaly.
    Mazziotti G, Marzullo P, Doga M, Aimaretti G, Giustina A.
    Trends Endocrinol Metab; 2015 Jan 01; 26(1):11-21. PubMed ID: 25434492
    [Abstract] [Full Text] [Related]

  • 18. Comorbidity and cardiovascular risk factors in adult GH deficiency following treatment for Cushing's disease or non-functioning pituitary adenomas during childhood.
    Ragnarsson O, Höybye C, Jönsson PJ, Feldt-Rasmussen U, Johannsson G, Biller BM, Koltowska-Häggström M.
    Eur J Endocrinol; 2012 Apr 01; 166(4):593-600. PubMed ID: 22258111
    [Abstract] [Full Text] [Related]

  • 19. Effect of growth hormone replacement therapy on the quality of life in women with growth hormone deficiency who have a history of acromegaly versus other disorders.
    Valassi E, Brick DJ, Johnson JC, Biller BM, Klibanski A, Miller KK.
    Endocr Pract; 2012 Apr 01; 18(2):209-18. PubMed ID: 22440981
    [Abstract] [Full Text] [Related]

  • 20. Baseline characteristics and the effects of two years of growth hormone (GH) replacement therapy in adults with GH deficiency previously treated for acromegaly.
    Norrman LL, Johannsson G, Sunnerhagen KS, Svensson J.
    J Clin Endocrinol Metab; 2008 Jul 01; 93(7):2531-8. PubMed ID: 18397981
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.